What is the first‑line therapy for acute group A streptococcal pharyngitis, including dosing for children and adults and alternatives for penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Streptococcal Pharyngitis

First-Line Therapy for Non-Allergic Patients

Penicillin V or amoxicillin for 10 days is the gold standard treatment for strep throat in patients without penicillin allergy. 1, 2

Dosing Regimens

Adults:

  • Penicillin V 250 mg orally 2–3 times daily (or 500 mg twice daily) for 10 days 1
  • Amoxicillin 500 mg orally twice daily for 10 days 2

Children:

  • Penicillin V 250 mg orally 2–3 times daily for 10 days 1
  • Amoxicillin 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days 3, 2

Amoxicillin is often preferred over penicillin V in children because of better palatability and more convenient dosing, though both have identical efficacy. 1, 2 Higher-dose amoxicillin (40–50 mg/kg/day) achieves superior clinical cure rates (88% vs 71%) and bacteriologic eradication (79% vs 55%) compared with lower-dose penicillin V. 3, 4

Why Penicillin Remains First-Line

  • Zero documented resistance worldwide – no Group A Streptococcus resistance to penicillin has ever been reported 1, 5
  • Narrow antimicrobial spectrum minimizes selection of resistant flora 1, 5
  • Proven efficacy in preventing acute rheumatic fever 1, 5
  • Lowest cost among all options 1, 5
  • Excellent safety profile 1

Intramuscular Option for Compliance Concerns

Benzathine penicillin G as a single intramuscular dose is preferred when adherence to oral therapy is uncertain: 1, 2

  • <27 kg: 600,000 units IM once 2
  • ≥27 kg: 1.2 million units IM once 1, 2

Treatment for Penicillin-Allergic Patients

Step 1: Determine Type of Allergic Reaction

The type of penicillin reaction dictates which alternatives are safe. 3

Immediate/anaphylactic reactions (anaphylaxis, angioedema, urticaria within 1 hour) carry up to 10% cross-reactivity with all beta-lactams including cephalosporins – these patients must avoid all beta-lactam antibiotics. 3, 2

Non-immediate/delayed reactions (mild rash >1 hour after exposure) have only 0.1% cross-reactivity with first-generation cephalosporins – these patients can safely receive cephalosporins. 3

For Non-Immediate Penicillin Allergy

First-generation cephalosporins are the preferred alternatives with strong, high-quality evidence: 3, 2

Adults:

  • Cephalexin 500 mg orally twice daily for 10 days 3, 2
  • Cefadroxil 1 gram orally once daily for 10 days 3

Children:

  • Cephalexin 20 mg/kg per dose twice daily (maximum 500 mg/dose) for 10 days 3, 2
  • Cefadroxil 30 mg/kg once daily (maximum 1 gram) for 10 days 3

For Immediate/Anaphylactic Penicillin Allergy

Clindamycin is the preferred choice with only ~1% resistance among U.S. Group A Streptococcus isolates and superior eradication rates even in chronic carriers: 3, 2

Adults:

  • Clindamycin 300 mg orally three times daily for 10 days 3, 2

Children:

  • Clindamycin 7 mg/kg per dose three times daily (maximum 300 mg/dose) for 10 days 3, 2

Macrolide alternatives (less preferred due to 5–8% resistance in the United States): 3, 5

Azithromycin:

  • Adults: 500 mg orally once daily for 5 days 3, 2
  • Children: 12 mg/kg once daily (maximum 500 mg) for 5 days 3, 2

Clarithromycin:

  • Adults: 250 mg orally twice daily for 10 days 3
  • Children: 7.5 mg/kg per dose twice daily (maximum 250 mg/dose) for 10 days 3

Erythromycin (least preferred due to high gastrointestinal side effects):

  • Erythromycin estolate: 20–40 mg/kg/day divided 2–3 times daily (maximum 1 gram/day) for 10 days 1, 3
  • Erythromycin ethylsuccinate: 40 mg/kg/day divided 2–3 times daily for 10 days 1

Critical Treatment Duration Requirements

A full 10-day course is mandatory for all antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent acute rheumatic fever. 3, 2, 5 Shortening the course by even a few days results in appreciable increases in treatment failure rates and rheumatic fever risk, even when symptoms resolve within 3–4 days. 3, 5

Azithromycin is the only exception, requiring only 5 days due to its prolonged tissue half-life. 3, 2

Therapy can be safely postponed up to 9 days after symptom onset and still prevent acute rheumatic fever. 3, 5


Treatment of Recurrent/Persistent Infections

For patients who fail initial therapy or chronic carriers, clindamycin is substantially more effective than penicillin or amoxicillin in eliminating chronic streptococcal carriage: 3, 2

Clindamycin:

  • Children: 20–30 mg/kg/day divided three times daily for 10 days 2
  • Adults: 600 mg/day in 2–4 equally divided doses for 10 days 2

Amoxicillin-clavulanate:

  • 40 mg/kg/day (amoxicillin component) divided three times daily (maximum 2000 mg amoxicillin/day) for 10 days 3, 2

Penicillin V plus rifampin:

  • Penicillin V 50 mg/kg/day divided four times daily (maximum 2000 mg/day) for 10 days
  • Plus rifampin 20 mg/kg/day once daily for the final 4 days (maximum 600 mg/day) 3

Adjunctive Symptomatic Treatment

Acetaminophen or NSAIDs (ibuprofen) should be offered for moderate to severe symptoms or high fever. 3, 2, 5 These provide modest benefit, shortening sore throat duration by only 1–2 days. 5

Aspirin is acceptable in adults but must be avoided in children due to Reye syndrome risk. 3, 2, 5

Corticosteroids are not recommended as adjunctive therapy. 3


Common Pitfalls to Avoid

  • Do not prescribe cephalosporins to patients with immediate/anaphylactic penicillin reactions due to 10% cross-reactivity risk 3, 2
  • Do not shorten the antibiotic course below 10 days (except azithromycin's 5-day regimen) as this markedly increases treatment failure and rheumatic fever risk 3, 2, 5
  • Do not use trimethoprim-sulfamethoxazole (Bactrim) – sulfonamides fail to eradicate Group A Streptococcus in 20–25% of cases 3
  • Do not use tetracyclines – they fail to eradicate the organism and do not prevent rheumatic fever 1, 3
  • Do not prescribe broad-spectrum antibiotics when narrow-spectrum penicillin/amoxicillin is appropriate, as this unnecessarily selects for resistant flora 1, 5
  • Do not order routine post-treatment throat cultures for asymptomatic patients who completed therapy; reserve testing for special circumstances such as history of rheumatic fever 3

Antibiotics to Avoid

The following agents should NOT be used for streptococcal pharyngitis:

  • Sulfonamides and tetracyclines have high resistance rates and frequent failure to eradicate even susceptible organisms 1
  • Trimethoprim-sulfamethoxazole fails in 20–25% of cases 3
  • Older fluoroquinolones (ciprofloxacin) have limited activity against Group A Streptococcus 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Strep Throat Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Adult Strep Throat Without Allergies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.